What the company does
Kukje Pharma makes prescription and over-the-counter medicines, including eye drops, soft-gel capsules, and oral tablets, used by patients across South Korea.
It supplies pharmacies, clinics, hospitals, and wholesale distributors through a nationwide sales force. Listed on KOSPI, Korea's main stock exchange, the company operates its own manufacturing and research facilities in Ansan, Gyeonggi Province, and is currently running several active drug-development programmes, including research into new drugs and improved formulations of existing ones.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$98.1M
- FY2024US$113.4M
- FY2025US$127.2M
Operating profit
- FY2023−US$1.4M
- FY2024US$4.9M
- FY2025US$4.5M
Net income
- FY2023−US$6.1M
- FY2024US$3.8M
- FY2025US$4.1M
Key ratios (FY2025)
Why it matters · Context, not a recommendation
The company maintains its own in-house manufacturing and research site in Ansan, giving it integrated production and development capabilities under one roof.
Filings
All disclosures · English when translatedPrice charts coming soon
Interactive price history isn't here yet. Would you use it?